Janet K. Cheetham

1.3k total citations
37 papers, 864 citations indexed

About

Janet K. Cheetham is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Janet K. Cheetham has authored 37 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Ophthalmology, 19 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Janet K. Cheetham's work include Retinal Development and Disorders (19 papers), Retinal Diseases and Treatments (17 papers) and Glaucoma and retinal disorders (14 papers). Janet K. Cheetham is often cited by papers focused on Retinal Development and Disorders (19 papers), Retinal Diseases and Treatments (17 papers) and Glaucoma and retinal disorders (14 papers). Janet K. Cheetham collaborates with scholars based in United States, United Kingdom and France. Janet K. Cheetham's co-authors include Jacque L. Duncan, Frederick L. Ferris, Karl G. Csaky, Emily Y. Chew, Prashant Nair, Ronald E. DeGryse, Allan Rosenthal, Amanda M. VanDenburgh, Rhett M. Schiffman and Ann‐Margret Ervin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Janet K. Cheetham

35 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet K. Cheetham United States 17 742 347 341 134 88 37 864
M. Bruce Shields United States 14 776 1.0× 143 0.4× 338 1.0× 153 1.1× 45 0.5× 32 929
Barbara Cvenkel Slovenia 17 669 0.9× 150 0.4× 364 1.1× 185 1.4× 20 0.2× 42 767
Chun Zhang China 14 350 0.5× 132 0.4× 217 0.6× 52 0.4× 26 0.3× 60 511
Jason L. Vittitow United States 17 946 1.3× 303 0.9× 343 1.0× 365 2.7× 92 1.0× 40 1.2k
Robert N. Weinreb United States 9 596 0.8× 130 0.4× 368 1.1× 76 0.6× 25 0.3× 13 664
Elizabeth Kimball United States 14 398 0.5× 211 0.6× 225 0.7× 41 0.3× 21 0.2× 26 486
Dayse F Sena United States 9 421 0.6× 191 0.6× 168 0.5× 39 0.3× 30 0.3× 15 497
David Dueker United States 12 686 0.9× 188 0.5× 448 1.3× 55 0.4× 15 0.2× 25 823
Kentaro Semba Japan 16 466 0.6× 185 0.5× 242 0.7× 24 0.2× 14 0.2× 25 604
Kwou‐Yeung Wu Taiwan 13 315 0.4× 96 0.3× 280 0.8× 85 0.6× 16 0.2× 42 494

Countries citing papers authored by Janet K. Cheetham

Since Specialization
Citations

This map shows the geographic impact of Janet K. Cheetham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet K. Cheetham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet K. Cheetham more than expected).

Fields of papers citing papers by Janet K. Cheetham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet K. Cheetham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet K. Cheetham. The network helps show where Janet K. Cheetham may publish in the future.

Co-authorship network of co-authors of Janet K. Cheetham

This figure shows the co-authorship network connecting the top 25 collaborators of Janet K. Cheetham. A scholar is included among the top collaborators of Janet K. Cheetham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet K. Cheetham. Janet K. Cheetham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, Ajoy, Wendi Liang, Maureen G. Maguire, et al.. (2025). Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association Study. American Journal of Ophthalmology. 276. 336–349.
2.
Birch, David G., Peiyao Cheng, Maureen G. Maguire, et al.. (2024). Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) Study. SHILAP Revista de lepidopterología. 5(2). 100648–100648.
3.
Duncan, Jacque L., Peiyao Cheng, Maureen G. Maguire, et al.. (2023). Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years. American Journal of Ophthalmology. 250. 103–110. 6 indexed citations
4.
Héon, Elise, Michele Melia, Laura E. Bocchino, et al.. (2023). Functional Vision in Patients With Biallelic USH2A Variants. American Journal of Ophthalmology. 260. 200–211. 1 indexed citations
5.
Birch, David G., Janet K. Cheetham, Stephen P. Daiger, et al.. (2023). Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel. Translational Vision Science & Technology. 12(6). 5–5. 9 indexed citations
6.
Birch, David G., Michele Melia, Jacque L. Duncan, et al.. (2022). The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene. Investigative Ophthalmology & Visual Science. 63(3). 17–17. 11 indexed citations
7.
Iannaccone, Alessandro, Carmen C. Brewer, Peiyao Cheng, et al.. (2021). Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A). American Journal of Medical Genetics Part A. 185(12). 3717–3727. 5 indexed citations
9.
Callanan, David, Derek Kunimoto, Raj K. Maturi, et al.. (2018). Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 34(10). 700–709. 55 indexed citations
10.
Genead, Mohamed A., et al.. (2014). Evaluation of the Test-Retest Reliability of the Electronic-ETDRS Visual Acuity Tester. Investigative Ophthalmology & Visual Science. 55(13). 163–163. 1 indexed citations
11.
Craven, E. Randy, Thomas R. Walters, Robert D. Williams, et al.. (2005). Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension. Journal of Ocular Pharmacology and Therapeutics. 21(4). 337–348. 56 indexed citations
12.
Cohen, John, Ronald L. Gross, Janet K. Cheetham, et al.. (2004). Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Survey of Ophthalmology. 49(2). S45–S52. 59 indexed citations
13.
Solomon, Kerry D., Eric D. Donnenfeld, Michael B. Raizman, et al.. (2004). Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients. Journal of Cataract & Refractive Surgery. 30(8). 1653–1660. 48 indexed citations
14.
Madhu, Cherukury, et al.. (2002). Systemic Pharmacokinetics of Bimatoprost 0.03% Solution Following Once Daily Ocular Dosing In Normal, Healthy Subjects. Investigative Ophthalmology & Visual Science. 43(13). 1085–1085. 2 indexed citations
15.
Brint, Stephen F., et al.. (1999). Efficacy and safety of nonpreservedketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy. Journal of Cataract & Refractive Surgery. 25(1). 41–49. 9 indexed citations
16.
Cheetham, Janet K., Ronald E. DeGryse, Monte S. Dirks, et al.. (1999). Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery:. American Journal of Ophthalmology. 127(3). 253–259. 58 indexed citations
17.
Stewart, Robert H., et al.. (1999). Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clinical Therapeutics. 21(4). 723–732. 34 indexed citations
18.
Gimbel, Howard V., et al.. (1996). Intraocular availability and pupillary effect of flurbiprofen and indomethacin during cataract surgery. Journal of Cataract & Refractive Surgery. 22(4). 474–479. 9 indexed citations
19.
Ginsburg, Arthur P., et al.. (1995). Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: Functional vision and contrast sensitivity. Journal of Cataract & Refractive Surgery. 21(1). 82–92. 31 indexed citations
20.
Tessler, Howard H., et al.. (1987). Reduction of Inflammation Following Cataract Surgery by the Nonsteroidal Anti-Inflammatory Drug, Flurbiprofen. Ophthalmic surgery, lasers & imaging retina. 18(12). 873–877. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026